Skip to main content
OpenTrials

Clinical trial condition

Non-alcoholic Fatty Liver Disease

Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

1,140 public trials 171 recruiting studies
Refine in advanced search Browse all conditions

Non-alcoholic Fatty Liver Disease trial results

Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

NCT07070362

Conditions
ARDS, Human, Acute Lung Injury, Acute Lung Injury(ALI), +26 more
Locations
  • Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine，Tsinghua University Beijing, Beijing Municipality, China
  • Peking University International Hospital Beijing, China
  • Southwest Hospital, The First Affiliated Hospital of Army Medical University Chongqing, China
  • Huangdao District People's Hospital of Qingdao Qingdao, China
View Trial Details
Recruiting

Quantifying Hepatic Mitochondrial Fluxes in Humans

NCT05305287

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +12 more
Locations
  • Texas Diabetes Institute - University Health System San Antonio, Texas, United States
  • University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

NCT07527910

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Southern California Research Center Coronado, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • Tandem Clinical Research, Plaza II Metairie, Louisiana, United States
  • Advanced Medical Trials Georgetown, Texas, United States
View Trial Details
Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07288138

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health - Peoria Peoria, Arizona, United States
  • Adobe Clinical Research, LLC Tucson, Arizona, United States
  • Arizona Liver Health - Tucson Tucson, Arizona, United States
View all 63 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT06419374

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Homewood, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
View all 321 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
  • 89bio Clinical Study Site Glendale, Arizona, United States
View all 365 locations
View Trial Details

Related conditions